Assessing the Usability and Clinical Utility of the Congo Red Dot Test: A Case-control Study

G

Gynuity Health Projects

Status

Completed

Conditions

Preeclampsia

Treatments

Device: Congo Red test GV-005

Study type

Observational

Funder types

Other

Identifiers

NCT02610972
4005A

Details and patient eligibility

About

A case-control study will evaluate the clinical utility of the Congo Red test GV-005 in following women with a clinical diagnosis of preeclampsia and clinically healthy women in the postpartum period

Full description

A case-control study (n=150) will evaluate the clinical utility of the Congo Red test GV-005 in following women with a clinical diagnosis of preeclampsia and clinically healthy women in the postpartum period. Women with preeclampsia (n=100) (cases) and clinically healthy women (n=50)(controls) who are hospitalized postpartum will be recruited for the trial. All women will be asked to provide a urine sample. Samples will be collected daily during a woman's hospitalization. The Congo Red test GV-005 and a standard urine dipstick proteinuria test will be performed by a lab technician within 72 hours of sample collection. The purpose of this research is to evaluate progression of urine congophilia postpartum by following patients diagnosed with preeclampsia and clinically healthy women.

Enrollment

150 patients

Sex

Female

Ages

18 to 64 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Postpartum
  • Clinical diagnosis of preeclampsia (severe, mild or superimposed) including eclampsia (n=100) OR Clinically healthy (n=50)
  • Eligible to consent for research
  • Agree to comply with study procedures
  • Able to give informed consent

Exclusion criteria

None

Trial design

150 participants in 2 patient groups

CLINICALLY CONFIRMED PREECLAMPSIA
Description:
Women clinically diagnosed with preeclampsia (severe, mild or superimposed) during pregnancy will provide a urine sample in the postpartum period to determine the presence or absence of proteinuria using the Congo Red test GV-005.
Treatment:
Device: Congo Red test GV-005
CLINICALLY HEALTHY
Description:
Women with a delivery of a healthy normal baby at term (induction of labor or an elective Caesarean Section) will provide a urine sample in the postpartum period to determine the presence or absence of proteinuria using the Congo Red test GV-005.
Treatment:
Device: Congo Red test GV-005

Trial documents
1

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems